Endovascular Hepatic Artery Stents in the Modern Management of Postpancreatectomy Hemorrhage. Issue 1 (8th March 2021)

• Record Type: Journal Article
• Authors: Finch, Louise M.; Baltatzis, Minas; Byott, Sam; Ganapathy, Anantha-Krishnan; Kakani, Nirmal; Lake, Edward; Cadwallader, Rosemary; Hazar, Can; Seriki, Dare; Butterfield, Stephen; Jegatheeswaran, Santhalingam; Jamdar, Saurabh; de Liguori Carino, Nicola; Siriwardena, Ajith K.
• Is Part Of: Annals of surgery open. Volume 2:Issue 1(2021)
• Page Start: e038
• Publication Date: 2021-03-08
• Subjects: endovascular stent -- hepatic artery -- postpancreatectomy hemorrhage; Surgery -- Periodicals; Surgery -- History -- Periodicals; General Surgery; Surgery; History; Periodicals; 616
• DOI: 10.1097/AS9.0000000000000038
• Languages: English
• ISSNs: 2691-3593

Abstract

Abstract : Background: Postoperative hemorrhage is a potentially lethal complication of pancreatoduodenectomy. This study reports on the use of endovascular hepatic artery stents in the management of postpancreatectomy hemorrhage. Methods: This is a retrospective analysis of a prospectively maintained, consecutive dataset of 440 patients undergoing pancreatoduodenectomy over 68 months. Data are presented on bleeding events and outcomes, and contextualized by the clinical course of the denominator population. International Study Group of Pancreatic Surgery terminology was used to define postpancreatectomy hemorrhage. Results: Sixty-seven (15%) had postoperative hemorrhage. Fifty (75%) were male and this gender difference was significant ( P = 0.001; 2 proportions test). Postoperative pancreatic fistulas were more frequent in the postoperative hemorrhage group ( P = 0.029; 2 proportions test). The median (interquartile range [IQR]) delay between surgery and postoperative hemorrhage was 5 days (2–14 days). Twenty-six (39%) required intervention comprising reoperation alone in 12, embolization alone in 5, and endovascular hepatic artery stent deployment in 5. Four further patients underwent more than 1 intervention with 2 of these having stents. Endovascular stent placement achieved initial hemostasis in 5 of 7 (72%). Follow-up was for a median (IQR) of 199 days (145–400 days) poststent placement. In 2 patients, the stent remained patent at last follow-up. The remaining 5 stents occluded with a median (IQR) period of proven patency of 10 days (8–22 days). Conclusions: This study shows that in the specific setting of postpancreatoduodenectomy hemorrhage with either a short remnant gastroduodenal artery bleed or a direct bleed from the hepatic artery, where embolization risks occlusion with compromise of liver arterial inflow, endovascular hepatic artery stent is an important hemostatic option but is associated with a high risk of subsequent graft occlusion. Abstract : Mini-abstract: In a consecutive cohort of 440 undergoing pancreatoduodenectomy, 67 had postpancreatectomy hemorrhage. Where embolization was impossible due either to short gastroduodenal artery remnant or bleed directly from hepatic artery, endovascular stent was deployed with initial hemostasis in 5 (72%). This study reports on endovascular hepatic artery stents in the modern management of postpancreatectomy hemorrhage.